First-in-human study of GFH018, a small molecule inhibitor of transforming growth factor-β receptor I inhibitor, in patients with advanced solid tumors.
- DOI
- 10.1186/s12885-024-12216-7
- Published
- 2024 Apr 10
- Container
- BMC cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s12885-024-12216-7,
title = {First-in-human study of GFH018, a small molecule inhibitor of transforming growth factor-β receptor I inhibitor, in patients with advanced solid tumors.},
author = {Guo Y and Wang Z and Zhou H and Pan H and Han W and Deng Y and Li Q and Xue J and Ge X and Wang S and Wang J and Zhang Y and Zhao C and Zhu H and Wang Y and Shen H and Liu D and Li J},
year = {2024},
journal = {BMC cancer},
doi = {10.1186/s12885-024-12216-7},
url = {https://doi.org/10.1186/s12885-024-12216-7}
}RIS
TY - JOUR TI - First-in-human study of GFH018, a small molecule inhibitor of transforming growth factor-β receptor I inhibitor, in patients with advanced solid tumors. AU - Guo Y AU - Wang Z AU - Zhou H AU - Pan H AU - Han W AU - Deng Y AU - Li Q AU - Xue J AU - Ge X AU - Wang S AU - Wang J AU - Zhang Y AU - Zhao C AU - Zhu H AU - Wang Y AU - Shen H AU - Liu D AU - Li J PY - 2024 JO - BMC cancer DO - 10.1186/s12885-024-12216-7 UR - https://doi.org/10.1186/s12885-024-12216-7 ER -
APA
Y, G., Z, W., H, Z., H, P., W, H., Y, D., Q, L., J, X., X, G., S, W., J, W., Y, Z., C, Z., H, Z., Y, W., H, S., D, L., & J, L. (2024). First-in-human study of GFH018, a small molecule inhibitor of transforming growth factor-β receptor I inhibitor, in patients with advanced solid tumors.. BMC cancer. https://doi.org/10.1186/s12885-024-12216-7
Source records
- pubmed · retrieved 2026-09-27T15:10:16.300Z